Free Trial

JPMorgan Claverhouse (LON:JCH) Reaches New 12-Month High - What's Next?

JPMorgan Claverhouse logo with Financial Services background

Key Points

  • JPMorgan Claverhouse's share price reached a new 52-week high of GBX 844 ($11.33) during trading, indicating strong market performance.
  • The company reported a net margin of 92.61% and a return on equity of 14.30%, highlighting its profitability and effective management.
  • With a market cap of £464.45 million, the investment trust focuses on UK large cap stocks with the ability to generate consistent and growing dividends since its establishment in 1963.
  • Five stocks to consider instead of JPMorgan Claverhouse.

JPMorgan Claverhouse (LON:JCH - Get Free Report)'s share price reached a new 52-week high during trading on Wednesday . The company traded as high as GBX 844 ($11.33) and last traded at GBX 844 ($11.33), with a volume of 66068 shares. The stock had previously closed at GBX 838 ($11.25).

JPMorgan Claverhouse Price Performance

The company has a debt-to-equity ratio of 11.85, a current ratio of 0.71 and a quick ratio of 67.67. The stock has a market cap of £464.45 million, a price-to-earnings ratio of 869.39 and a beta of 0.83. The stock has a fifty day moving average of GBX 807.15 and a 200 day moving average of GBX 776.13.

JPMorgan Claverhouse (LON:JCH - Get Free Report) last announced its quarterly earnings data on Thursday, August 14th. The investment trust reported GBX 18.96 EPS for the quarter. JPMorgan Claverhouse had a net margin of 92.61% and a return on equity of 14.30%.

JPMorgan Claverhouse Company Profile

(Get Free Report)

Great British dividends The JPMorgan Claverhouse Investment Trust has been helping investors tap directly into the long-term growth potential of UK large cap stocks since 1963. The trust focuses on attractively valued, high quality stocks with the ability to generate consistent and growing dividends. Key points Expertise • Managed by an investment team with long-standing UK equity experience, backed by the extensive resources of J.P.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in JPMorgan Claverhouse Right Now?

Before you consider JPMorgan Claverhouse, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JPMorgan Claverhouse wasn't on the list.

While JPMorgan Claverhouse currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.